ProfileGDS4718 / 226479_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 44% 30% 76% 26% 46% 77% 78% 45% 39% 52% 53% 43% 69% 86% 71% 60% 67% 88% 73% 41% 39% 50% 56% 54% 53% 81% 54% 77% 50% 77% 73% 73% 22% 39% 75% 82% 72% 39% 39% 76% 61% 79% 69% 85% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.219744
GSM549102patient 115, normal, homogenized [OPG study]4.5765230
GSM549104patient 119, normal, homogenized [OPG study]7.4598976
GSM549108patient 138, normal, homogenized [OPG study]4.4336226
GSM549119patient 077, normal, homogenized [OPG study]5.2951746
GSM549133patient 032, cancer, homogenized [OPG study]7.6631277
GSM549139patient 042, cancer, homogenized [OPG study]7.6959278
GSM549099patient 107, normal, homogenized [OPG study]5.2762945
GSM549109patient 139, normal, homogenized [OPG study]4.9769639
GSM549110patient 046, normal, homogenized [OPG study]5.6075452
GSM549114patient 063, normal, homogenized [OPG study]5.6476753
GSM549122patient 082, normal, homogenized [OPG study]5.1368343
GSM549134patient 033, cancer, homogenized [OPG study]6.7764869
GSM549136patient 036, cancer, homogenized [OPG study]8.6683586
GSM549140patient 044, cancer, homogenized [OPG study]7.0152971
GSM549111patient 047, normal, homogenized [OPG study]6.1616860
GSM549113patient 057, normal, homogenized [OPG study]6.606267
GSM549132patient 031, cancer, homogenized [OPG study]8.8678988
GSM549137patient 038, cancer, homogenized [OPG study]7.1736873
GSM549142patient 047, cancer, homogenized [OPG study]5.1707341
GSM549100patient 110, normal, homogenized [OPG study]4.9589439
GSM549107patient 135, normal, homogenized [OPG study]5.4662250
GSM549115patient 068, normal, homogenized [OPG study]5.8019456
GSM549116patient 072, normal, homogenized [OPG study]5.7078754
GSM549120patient 078, normal, homogenized [OPG study]5.675153
GSM549131patient 030, cancer, homogenized [OPG study]8.0460881
GSM549118patient 074, normal, homogenized [OPG study]5.7315554
GSM549129patient 027, cancer, homogenized [OPG study]7.6115577
GSM549123patient 088, normal, homogenized [OPG study]5.4949450
GSM549124patient 006, cancer, homogenized [OPG study]7.4344877
GSM549126patient 015, cancer, homogenized [OPG study]7.14973
GSM549128patient 025, cancer, homogenized [OPG study]7.1961573
GSM549103patient 117, normal, homogenized [OPG study]4.2789622
GSM549117patient 073, normal, homogenized [OPG study]4.9218539
GSM549138patient 041, cancer, homogenized [OPG study]7.3928175
GSM549141patient 045, cancer, homogenized [OPG study]8.2459182
GSM549130patient 028, cancer, homogenized [OPG study]7.0409972
GSM549101patient 111, normal, homogenized [OPG study]4.9623139
GSM549105patient 128, normal, homogenized [OPG study]4.9669239
GSM549106patient 134, normal, homogenized [OPG study]7.5819476
GSM549112patient 048, normal, homogenized [OPG study]6.2059161
GSM549125patient 011, cancer, homogenized [OPG study]7.6875879
GSM549127patient 024, cancer, homogenized [OPG study]6.8546869
GSM549135patient 035, cancer, homogenized [OPG study]8.5175485